Profile
James D.
Laur is currently Director at Prometheus Laboratories, Inc. since 2020, Director at Gemelli Biotech Corp., and Chief Intellectual Property Officer & MD at Cedars-Sinai Technology Ventures (Venture Capital) since 2021.
Former positions include Director at Prometheus Biosciences, Inc. from 2020 to 2023 and Member of the California State Bar Association.
Education includes an undergraduate degree from the University of California, Los Angeles in 1983 and a graduate degree from Boston College Law School in 1986.
James Laur active positions
| Companies | Position | Start |
|---|---|---|
Gemelli Biotech Corp.
Gemelli Biotech Corp. BiotechnologyHealth Technology Operates as a biotechnology company | Director/Board Member | - |
Prometheus Laboratories, Inc.
Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel pharmaceutical and diagnostic products | Director/Board Member | 01/04/2020 |
The Cedars-Sinai Accelerator
The Cedars-Sinai Accelerator Investment ManagersFinance Cedars-Sinai invests in companies located in the United States. The firm focuses on the healthcare. It participates in seed and early stage capital requirements with an investment size of USD 0.50 - 5 million. The firm makes follow-on investments. | Private Equity Investor | 01/07/2021 |
Former positions of James Laur
| Companies | Position | End |
|---|---|---|
| PROMETHEUS BIOSCIENCES, INC. | Director/Board Member | 16/06/2023 |
California State Bar Association | Corporate Officer/Principal | - |
Training of James Laur
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Prometheus Laboratories, Inc.
Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel pharmaceutical and diagnostic products | Health Technology |
California State Bar Association | |
Boston College Law School
Boston College Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Prometheus Biosciences, Inc.
Prometheus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops medicines for immune-mediated diseases | Health Technology |
Gemelli Biotech Corp.
Gemelli Biotech Corp. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
The Cedars-Sinai Accelerator
The Cedars-Sinai Accelerator Investment ManagersFinance Cedars-Sinai invests in companies located in the United States. The firm focuses on the healthcare. It participates in seed and early stage capital requirements with an investment size of USD 0.50 - 5 million. The firm makes follow-on investments. | Finance |
- Stock Market
- Insiders
- James Laur
















